G Viale

Author PubWeight™ 201.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997 6.99
2 Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol 2002 4.32
3 Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996 3.07
4 Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999 2.90
5 Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009 2.75
6 bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol 1997 2.66
7 The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 1996 2.57
8 Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol 2001 2.42
9 p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001 2.19
10 Patterns of integrin common chain beta 1 and collagen IV immunoreactivity in hepatocellular carcinoma. Correlations with tumour growth rate, grade and size. J Pathol 1993 2.12
11 Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 2002 2.03
12 Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. Ann Oncol 2010 2.02
13 1st International consensus guidelines for advanced breast cancer (ABC 1). Breast 2012 1.96
14 Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. Ann Oncol 2012 1.69
15 Outcome of special types of luminal breast cancer. Ann Oncol 2011 1.67
16 Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol 2010 1.65
17 Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. Ann Oncol 2005 1.60
18 Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med 2001 1.57
19 Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 2003 1.55
20 Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Ann Oncol 2007 1.54
21 Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998 1.53
22 Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996 1.52
23 The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer 1994 1.51
24 Should liver metastases of breast cancer be biopsied to improve treatment choice? Ann Oncol 2011 1.50
25 Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol 2010 1.47
26 Quality indicators in breast cancer care. Eur J Cancer 2010 1.46
27 Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann Oncol 2014 1.45
28 The problem of the accuracy of intraoperative examination of axillary sentinel nodes in breast cancer. Ann Surg Oncol 2001 1.45
29 Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase. Ann Oncol 2003 1.42
30 Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO). Breast Cancer Res Treat 2009 1.41
31 Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res 1995 1.39
32 Immunoreactivity for latent membrane protein 1 of Epstein-Barr virus in nevi and melanomas is not related to the viral infection. Virchows Arch 2000 1.39
33 Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 1994 1.35
34 p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol 1995 1.32
35 A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol 2006 1.29
36 Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene 2007 1.28
37 The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol 2008 1.23
38 Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg 1999 1.22
39 Pulmonary epithelial-myoepithelial tumor of unproven malignant potential: report of a case and review of the literature. Mod Pathol 2001 1.22
40 bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum Pathol 1995 1.21
41 Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse. Ann Oncol 2012 1.19
42 Vasoactive intestinal polypeptide-, somatostatin-, and calcitonin-producing adrenal pheochromocytoma associated with the watery diarrhea (WDHH) syndrome. First case report with immunohistochemical findings. Cancer 1985 1.18
43 Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy. Ann Oncol 2007 1.17
44 Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor. Oncogene 2009 1.16
45 A simplified procedure for the preparation of antibodies to serum fibronectin. J Immunol Methods 1980 1.13
46 Resection of pulmonary blebs and pleurodesis for spontaneous pneumothorax. Chest 1993 1.12
47 Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes. Breast Cancer Res Treat 2011 1.12
48 Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. Int J Cancer 1996 1.11
49 Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody. Am J Pathol 1999 1.10
50 Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies. Ann Oncol 2004 1.10
51 p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer 1997 1.10
52 Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol 1999 1.10
53 Discrete regions of HIV-1 gp41 defined by syncytia-inhibiting affinity-purified human antibodies. AIDS 1993 1.09
54 Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects. Q J Nucl Med 2002 1.08
55 Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001 1.07
56 The clinical significance of p53 aberrations in human tumours. Virchows Arch 1995 1.06
57 Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol 2007 1.06
58 Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol 2006 1.06
59 Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay. J Immunol 1998 1.06
60 Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives. J Allergy Clin Immunol 1983 1.06
61 Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. Br J Cancer 2007 1.04
62 Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective. Ann Oncol 2012 1.04
63 A study of immunoglobulin classes present on the membrane and in the cytoplasm of human tonsil plasma cells. Eur J Immunol 1976 1.04
64 The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch 1994 1.03
65 Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity. Br J Cancer 2008 1.02
66 Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol 2012 1.01
67 Comparative study of membrane and intracytoplasmic immunoglobulin classes in human lymphoid cells. Ann N Y Acad Sci 1975 1.01
68 IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes. J Immunol 1995 1.01
69 Lymphocyte membrane receptors in human lymphoid leukemias. Eur J Immunol 1975 1.00
70 Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Ann Oncol 2011 1.00
71 p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix. J Pathol 1993 0.98
72 Breast cancer subtypes and outcome after local and regional relapse. Ann Oncol 2011 0.98
73 Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors. Ann Oncol 2000 0.98
74 Choroid plexus tumors. An immunocytochemical study with particular reference to the coexpression of intermediate filament proteins. Am J Pathol 1987 0.97
75 Lymphatic mapping to tailor selective lymphadenectomy in cN0 tongue carcinoma: beyond the sentinel node concept. Eur J Nucl Med Mol Imaging 2006 0.97
76 p53 accumulation in ovarian carcinomas and its prognostic implications. Hum Pathol 1993 0.97
77 The effect of metformin on apoptosis in a breast cancer presurgical trial. Br J Cancer 2013 0.96
78 Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions. Eur J Nucl Med Mol Imaging 2003 0.96
79 Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer 2013 0.96
80 Extracardiac rhabdomyoma: An immunocytochemical study and review of the literature. Appl Pathol 1988 0.94
81 Evidence of Epstein-Barr virus infection in ulcerative colitis. Dig Liver Dis 2001 0.94
82 T-cell subsets in sarcoidosis: an immunocytochemical investigation of blood, bronchoalveolar lavage fluid, and prescalenic lymph nodes from eight patients. Hum Pathol 1986 0.94
83 Insulin-like growth factor 1 expression in thyroid tumors. Appl Immunohistochem Mol Morphol 2000 0.93
84 Prediction of response to primary chemotherapy for operable breast cancer. Eur J Cancer 1999 0.92
85 Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay. Ann Oncol 2002 0.92
86 Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer. Breast Cancer Res Treat 2012 0.92
87 Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options. Eur J Surg Oncol 2005 0.90
88 Sentinel lymph node biopsy for localised ductal carcinoma in situ? Breast 2005 0.90
89 Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial. Ann Oncol 2011 0.90
90 Gastric giardiasis. J Clin Pathol 1992 0.90
91 Additional prognostic value of the 70-gene signature (MammaPrint(®)) among breast cancer patients with 4-9 positive lymph nodes. Breast 2013 0.90
92 Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer. Ann Oncol 2011 0.90
93 Characterization of IgD. II. Molecular forms of IgD in human B cells. Scand J Immunol 1979 0.89
94 Clear cell odontogenic carcinoma. Report of two cases and review of the literature. Am J Clin Pathol 2001 0.89
95 Preoperative systemic treatment: prediction of responsiveness. Breast 2003 0.89
96 Differences in the organization and chromosomal allocation of satellite DNA between the European long tailed house mice Mus domesticus and Mus musculus. Chromosoma 1990 0.89
97 Pancreatic (acinar) metaplasia of the gastric mucosa. Histology, ultrastructure, immunocytochemistry, and clinicopathologic correlations of 101 cases. Am J Surg Pathol 1993 0.88
98 Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype. Ann Oncol 2005 0.88
99 Sebaceous lymphadenoma of salivary gland: a case report and a review of the literature. Acta Otorhinolaryngol Ital 2007 0.88
100 A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer. Ann Oncol 2009 0.88
101 HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH? Ann Oncol 2012 0.88
102 Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer 2001 0.87
103 Posterior polymorphous dystrophy of the cornea. An ultrastructural study. Graefes Arch Clin Exp Ophthalmol 1985 0.87
104 Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas. Int J Immunopathol Pharmacol 2008 0.87
105 Genome distribution, chromosomal allocation, and organization of the major and minor satellite DNAs in 11 species and subspecies of the genus Mus. Cytogenet Cell Genet 1993 0.87
106 Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection. World J Surg 2001 0.87
107 CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours. Virchows Arch 2000 0.86
108 Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials. Ann Oncol 2013 0.86
109 p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Ann Oncol 2008 0.85
110 Membrane Ig on human lymphocytes: rate of turnover of IgD and IgM on the surface of human tonsil cells. Eur J Immunol 1976 0.85
111 The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up. Ann Oncol 2009 0.84
112 Down-regulation of beta(1C) integrin in breast carcinomas correlates with high proliferative fraction, high histological grade, and larger size. Am J Pathol 2000 0.84
113 Immunoreactivity for p27(KIP1) and cyclin E is an independent predictor of survival in primary gastric non-Hodgkin's lymphoma. Int J Cancer 2001 0.84
114 Development of axillary surgery in breast cancer. Ann Oncol 2005 0.84
115 [Surgical treatment and prognosis in traumatic cerebral lesions]. Sist Nerv 1969 0.84
116 Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up. Virchows Arch A Pathol Anat Histopathol 1992 0.84
117 Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres and a high content of EBV-infected large B-cells carrying IgH chain gene monoclonal rearrangement. Histopathology 2005 0.84
118 Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer. Br J Cancer 2007 0.84
119 Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions. Acta Cytol 1997 0.83
120 Poorly differentiated synovial sarcoma of the vagina: first reported case with immunohistochemical, molecular and ultrastructural data. Histopathology 2007 0.83
121 The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha. Leukemia 2011 0.83
122 Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). J Pathol 1997 0.83
123 Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids. Am J Surg Pathol 1996 0.83
124 Immunocytochemical localization of progesterone receptors in endocrine cells of the human pancreas. Am J Pathol 1990 0.83
125 Cell cycle-related gene abnormalities and product expression in esophageal carcinoma. Lab Invest 1998 0.82
126 Ultrastructural localization of extracellular immunoglobulins in immune-complex-mediated glomerulonephritis. Immunoelectron microscopy of Epon-embedded human renal biopsies using the immunogold staining procedure. Histochemistry 1986 0.82
127 The outcome from acute subdural and epidural intracranial haematomas in very elderly patients. Br J Neurosurg 1992 0.82
128 Common acute lymphoblastic leukaemia-lymphoma expressing cytokeratin: a case report. Virchows Arch 1994 0.82
129 Coexpression of intermediate filaments in normal and neoplastic human tissues: a reappraisal. Ultrastruct Pathol 1989 0.82
130 Ultrastructural immunolabeling in renal diseases. Past, present and future expectations. Pathol Immunopathol Res 1987 0.81
131 Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial. Ann Oncol 2013 0.81
132 Clinical relevance of microvessel density in laryngeal squamous cell carcinomas. Int J Cancer 2001 0.81
133 European multicentre study on melanoma immunoscintigraphy by means of 99mTc-labelled monoclonal antibody fragments. The European Multicentre Study Group. Eur J Nucl Med 1990 0.81
134 Long-term follow-up of the surgical treatment of intracranial coenurosis. Br J Neurosurg 1990 0.81
135 Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design. Breast 2011 0.81
136 Insulin-like growth factor-I expression in normal and diseased endometrium. Int J Cancer 1999 0.81
137 Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study. Ann Oncol 2009 0.81
138 A simple and reproducible prognostic index in luminal ER-positive breast cancers. Ann Oncol 2013 0.81
139 Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure. Breast Cancer Res Treat 2009 0.81
140 Inhibition of matrix metalloproteinases by over-expression of tissue inhibitor of metalloproteinase-2 inhibits the growth of experimental hemangiomas. Int J Cancer 2001 0.81
141 Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology. Ann Surg Oncol 2014 0.81
142 Rhabdoid tumours of the central nervous system. Report of three cases with immunocytochemical and ultrastructural findings. Virchows Arch A Pathol Anat Histopathol 1993 0.80
143 Lymphoepithelial cysts of salivary glands: an immunohistochemical study of HIV-related and HIV-unrelated lesions. Hum Pathol 1998 0.80
144 Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa. J Pathol 1998 0.80
145 Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study. Ann Oncol 2007 0.80
146 Laryngeal carcinoma showing multidirectional epithelial neuroendocrine and sarcomatous differentiation. ORL J Otorhinolaryngol Relat Spec 1990 0.80
147 The prevalence and clinical implications of c-kit expression in plasma cell myeloma. Histopathology 2006 0.80
148 Expression of EDA/EDB isoforms of fibronectin in papillary carcinoma of the thyroid. J Pathol 1999 0.80
149 Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Ann Oncol 2008 0.80
150 Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen. Anticancer Res 2002 0.79
151 C-myc and tumour suppressor gene product expression in developing and term human trophoblast. Placenta 1994 0.79
152 High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy. Eur J Cancer 2013 0.79
153 Medical decision making for melanoma of the glans penis. J Exp Clin Cancer Res 1999 0.79
154 Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions. An immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 1990 0.79
155 Mastectomy without radiotherapy: outcome analysis after 10 years of follow-up in a single institution. Breast Cancer Res Treat 2012 0.79
156 Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial. Ann Oncol 2008 0.79
157 Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype. Br J Cancer 2013 0.79
158 Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5. Nucl Med Commun 1988 0.79
159 Cellular heterogeneity of granular cell tumours: a clue to their nature? J Oral Pathol Med 2000 0.78
160 Prognostic value of N-myc immunoreactivity in medullary thyroid carcinoma. Cancer 1994 0.78
161 Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer. Br J Cancer 2008 0.78
162 Abnormal p53 expression in lung neuroendocrine tumors. Diagnostic and prognostic implications. Diagn Mol Pathol 1992 0.78
163 Pre-operative chemotherapy and radiotherapy in breast cancer. Eur J Cancer 1998 0.78
164 Preparation and characterization of anti-human chromogranin A and chromogranin B (secretogranin I) monoclonal antibodies. Mol Cell Probes 1989 0.78
165 Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging. Cancer Res 2000 0.78
166 Malignant rhabdoid tumour of the uterus: an immunohistochemical and ultrastructural study. Virchows Arch A Pathol Anat Histopathol 1992 0.78
167 Deeply invasive squamous cell carcinoma of the conjunctiva: case report. Int Ophthalmol 1990 0.77
168 Ultrastructural immunolabeling in the diagnosis of light-chain-related renal disease. Pathol Immunopathol Res 1986 0.77
169 Idiotypic replica of an anti-human tumour-associated antigen monoclonal antibody. DNA sequence comparison between Ab1 and Ab3. Scand J Immunol 1991 0.77
170 Monoclonal proliferation of germinal center cells (incipient follicular lymphoma) in an axillary lymph node of a melanoma patient. Hum Pathol 2001 0.77
171 The commitment of secretory cells to the selective expression of immunoglobulin CH genes is determined by the available concentrations of the triggering ligand. Eur J Immunol 1986 0.77
172 [Acute hepatic failure and renal damage. Experimental and clinical studies]. Minerva Med 1978 0.77
173 Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice. Anticancer Res 1999 0.77
174 Immunohistochemical localization of human immunoglobulins and lysozyme in epoxy-embedded lymph nodes: effect of different fixatives and of proteolytic digestion. J Histochem Cytochem 1982 0.77
175 Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression. Breast Cancer Res Treat 2015 0.76
176 Tips and tricks in triple-negative breast cancer: how to manage patients in real-life practice? Ecancermedicalscience 2011 0.76
177 Peptide receptors in neuroendocrine tumors of the lung as potential tools for radionuclide diagnosis and therapy. Q J Nucl Med Mol Imaging 2006 0.76
178 The angiogenesis marker ED-B+ fibronectin isoform in intracranial meningiomas. Acta Neurochir (Wien) 2000 0.76
179 Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study. Ann Oncol 2013 0.76
180 Positive identification in situ of mRNA expression of IL-6, and IL-12, and the chemotactic cytokine RANTES in patients with chronic sinusitis and polypoid disease. Clinical relevance and relation to allergy. Acta Otolaryngol 1996 0.75
181 Nasal messenger RNA expression of interleukins 2, 4, and 5 in patients with allergic rhinitis. Diagn Mol Pathol 1995 0.75
182 Resection of colorectal liver metastases following neoadjuvant chemotherapy. Ecancermedicalscience 2007 0.75
183 Metastasis to the right stellate ganglion and vagal nerve: pathological alterations causing sudden death. A case report. Acta Otorhinolaryngol Ital 2012 0.75
184 Ultrasound-guided vacuum-assisted breast biopsy: Use at the European Institute of Oncology in 2010. J Ultrasound 2011 0.75
185 Choroid plexus papillomas. Histopathology 1990 0.75
186 Distribution of tenascin in human malignant gliomas is not related to cell proliferation. J Neurol Neurosurg Psychiatry 1997 0.75
187 Risk factors for relapse after conservative treatment in T1-T2 breast cancer with one to three positive axillary nodes: results of an observational study. Ann Oncol 2010 0.75
188 [Principles of surgery of saccular endocranial aneurysm]. Resen Clin Cient 1971 0.75
189 Partial irradiation of the breast: Old challenges, new solutions. Breast 2006 0.75
190 [On some angiographic diagnostic problems in traumatic intracranial pathology of surgical importance]. Minerva Neurochir 1967 0.75
191 RANTES is more prevalent in bacterial than in nonbacterial maxillary sinusitis: and P-selectin is preferentially up-regulated in diseased mucosae. Arch Otolaryngol Head Neck Surg 1997 0.75
192 Hypothalamic target cells of endogenous sexual steroids in female rat. An immunocytochemical approach utilizing antiestradiol antiserum. J Hirnforsch 1989 0.75
193 Transforming growth factor beta 1 (TGF-beta 1) expression in proliferating thyroid disease. Int J Oncol 1996 0.75
194 Cathepsin D is a marker of ganglion cell differentiation in the developing and neoplastic human peripheral sympathetic nervous tissues. Virchows Arch 2000 0.75
195 Accumulation of oncofetal fibronectin in the vessels of anaplastic meningiomas. J Neurol Neurosurg Psychiatry 1998 0.75
196 Aneurysms of the Bifurcation of the internal carotid artery. Acta Neurochir (Wien) 1968 0.75
197 Reduction of insulin resistance after correction of nonneoplastic ovarian virilization. J Endocrinol Invest 1993 0.75
198 [Urinary excretion of the catabolites of progesterone in gestosis of the third trimester]. Boll Soc Ital Biol Sper 1970 0.75
199 Gangliocytic paraganglioma of the duodenum: case report. Tumori 1987 0.75
200 Hepatocellular cytoskeleton reorganization after phalloidin intoxication. An immuno-morphological view. Cell Mol Biol 1988 0.75
201 Blood group substance, CEA, and lectins in ovarian tumors. Cancer Detect Prev 1986 0.75
202 Antiidiotypic antibodies mimic molecular and functional properties of human IL-1 beta in vitro and in vivo. Lymphokine Cytokine Res 1994 0.75
203 Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast. Breast Cancer Res Treat 2014 0.75
204 Expression of new phenotypic markers in cholangiocarcinoma and putative precursor lesions. J Surg Oncol Suppl 1993 0.75
205 Extracellular matrix proteins, integrin receptors (VLA-beta 1, VLA-alpha 2 and VLA-alpha 5) and growth fraction in atypical macroregenerative nodules of the liver: an immunocytochemical case study. Histochemistry 1994 0.75
206 [Intra- and postoperative cerebral blood flow in patients with subarachnoid hemorrhage from a ruptured aneurysm]. Minerva Anestesiol 1993 0.75
207 Chromosomal distribution of the major satellite DNA of South American rodents of the genus Ctenomys. Cytogenet Cell Genet 1995 0.75
208 Combined extra- and intradural temporal approach for retrogasserian rhizotomy--technical note. Neurochirurgia (Stuttg) 1970 0.75
209 Salivary gland choristoma in large bowel. Endoscopy 2012 0.75
210 [Possible physiopathologic phenomenon in the origin of so-called spontaneous cerebral hemorrhages]. Minerva Neurochir 1971 0.75
211 Medullary thyroid carcinoma in multiple endocrine neoplasm type II syndromes. Tumori 1985 0.75
212 Bcl-2 immunoreactivity in salivary gland neoplasms is unrelated to the expression of mRNA for natural killer cell stimulatory cytokines interleukin (IL)-2 and IL-12. Virchows Arch 1996 0.75
213 Cytokeratin immunocytochemistry in the practice of diagnostic histopathology. Ultrastruct Pathol 1989 0.75
214 Molecular analysis of sentinel lymph nodes and search for molecular signatures of the metastatic potential of breast cancer. Q J Nucl Med Mol Imaging 2014 0.75
215 Assessment of response in primary chemotherapy for breast cancer. Ann Oncol 1998 0.75
216 In vivo imaging of chromogranin A-positive endocrine tumours by three-step monoclonal antibody targeting. Eur J Nucl Med 1996 0.75
217 Radiolocalization of 99mTc-labeled fragments in a melanoma xenografted model. J Nucl Biol Med 1991 0.75
218 Immunoelectron microscopy of human renal biopsies: prerequisites and limitations. Appl Pathol 1984 0.75
219 [Our experience with prevention of fetal erythroblastosis due to Rh]. Ann Ostet Ginecol Med Perinat 1972 0.75
220 [Psammomatous somatostatinoma of Vater's papilla. A case report]. Minerva Med 1989 0.75
221 Sarcomatous carcinoma of the kidney presenting as spontaneous retroperitoneal hemorrhage. Report of a case with immunocytochemical study. Eur Urol 1988 0.75
222 Adult nephroblastoma induced erythrocytosis. Report of a case and review of the literature. Scand J Urol Nephrol 1990 0.75
223 Plasma cell granuloma of the lung (inflammatory pseudotumor). Tumori 1986 0.75
224 Rare presentation of small bowel leiomyosarcoma with liver metastases. J Exp Clin Cancer Res 1999 0.75
225 Ultrastructural localization of intracellular immunoglobulins in Epon-embedded human lymph nodes. An immunoelectron microscopic investigation using the immunogold staining (IGS) and the avidin-biotin-peroxidase complex (ABC) methods. J Histochem Cytochem 1985 0.75